Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kunitoshi Kamijima, Moriyoshi Yasuda, Kayo Yamamura & Yasuhiko Fukuta. (2018) Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder. Current Medical Research and Opinion 34:12, pages 2105-2112.
Read now
Read now
Articles from other publishers (37)
Eva Češková. (2023) Latest advances in psychopharmacotherapy: what a pharmacist should know. Farmacie pro praxi 19:1, pages 15-18.
Crossref
Crossref
Adam Montgomery, Marianna Rogowska & Luiz Dratcu. (2023) Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?. Clinical Psychopharmacology and Neuroscience 21:1, pages 202-206.
Crossref
Crossref
Gudrun Hefner, Jan Wolff, Sermin Toto, Pamela Reißner & Ansgar Klimke. (2022) Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry. Journal of Neural Transmission 129:11, pages 1353-1365.
Crossref
Crossref
Jolanta Orzelska-Górka, Joanna Mikulska, Anna Wiszniewska & Grażyna Biała. (2022) New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. International Journal of Molecular Sciences 23:18, pages 10624.
Crossref
Crossref
Roger W. Sommi, Bhaskar Rege, Angela Wehr, Sejal Faldu, Yangchun Du & Peter J. Weiden. (2020) Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals. CNS Spectrums 27:3, pages 262-267.
Crossref
Crossref
Minze Zhu, Andrew K. Whittaker, Felicity Y. Han & Maree T. Smith. (2022) Journey to the Market: The Evolution of Biodegradable Drug Delivery Systems. Applied Sciences 12:2, pages 935.
Crossref
Crossref
Shabnoor Iqbal, Muhammad Ajmal Shah, Azhar Rasul, Shahid Shah, Ghulam Mujtaba Shah, Muhammad Irfan, Uzma Saleem, Ifat Alsharif, Reem Hasaballah Alhasani, Norah A. Althobaiti, Shafiq Ur Rahman & Abdul Haleem Khan. 2022. The Role of Phytonutrients in Metabolic Disorders. The Role of Phytonutrients in Metabolic Disorders
313
358
.
Carlo Romano Settanni, Gianluca Ianiro, Stefano Bibbò, Giovanni Cammarota & Antonio Gasbarrini. (2021) Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, pages 110258.
Crossref
Crossref
Kunal Maini, Janice W. Hollier, Haley Gould, Victoria Bollich, John LaForge, Elyse M. Cornett, Amber N. Edinoff, Adam M. Kaye & Alan D. Kaye. (2021) Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. Health Psychology Research 9:1.
Crossref
Crossref
Marsal Sanches, Joao Quevedo & Jair C. Soares. (2021) New agents and perspectives in the pharmacological treatment of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110157.
Crossref
Crossref
Cara Hoepner, Roger McIntyre & George Papakostas. (2021) Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence. Nutrients 13:3, pages 767.
Crossref
Crossref
Supriya Mishra, Vikram Jeet Singh, Pooja A Chawla & Viney Chawla. (2021) Neuroprotective Role of Nutritional Supplementation in Athletes. Current Molecular Pharmacology 15:1, pages 129-142.
Crossref
Crossref
Mahsa Sadat Zia, Elham Afkhami, Hamid Taher Neshat-Doost, Mahgol Tavakoli, Hossein Ali Mehrabi Kooshki & Laura Jobson. (2020) A brief clinical report documenting a novel therapeutic technique (MEmory Specificity Training, MEST) for depression: a summary of two pilot randomized controlled trials. Behavioural and Cognitive Psychotherapy 49:1, pages 118-123.
Crossref
Crossref
Samia Joca, Gabriela P. Silote, Ariandra Sartim, Amanda Sales, Francisco Guimarães & Gregers Wegener. 2021. The Neuroscience of Depression. The Neuroscience of Depression
459
467
.
Bastian Schirmer & Roland Seifert. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021
109
125
.
Alexei Verkhratsky, Vladimir Parpura, Caterina Scuderi & Baoman Li. 2021. Astrocytes in Psychiatric Disorders. Astrocytes in Psychiatric Disorders
317
347
.
Daniil Grinchii & Eliyahu Dremencov. (2020) Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders. International Journal of Molecular Sciences 21:24, pages 9532.
Crossref
Crossref
E. Leahy, M. Varney & D. Brunner. 2020. Phenotypic Drug Discovery. Phenotypic Drug Discovery
175
197
.
Aila J. Ahola, Lina Radzeviciene, Linda Zaharenko, Tomislav Bulum, Sabīne Skrebinska, Edita Prakapiene, Kristina Blaslov, Vinko Roso, Vita Rovite, Valdis Pirags, Lea Duvnjak, Jelizaveta Sokolovska, Rasa Verkauskiene & Carol Forsblom. (2020) Association between symptoms of depression, diabetes complications and vascular risk factors in four European cohorts of individuals with type 1 diabetes – InterDiane Consortium. Diabetes Research and Clinical Practice 170, pages 108495.
Crossref
Crossref
. (2020) AANP Forum. The Journal for Nurse Practitioners 16:9, pages A17-A20.
Crossref
Crossref
Richard J. Zeifman, Anne C. Wagner, Ros Watts, Hannes Kettner, Lea J. Mertens & Robin L. Carhart-Harris. (2020) Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Frontiers in Psychiatry 11.
Crossref
Crossref
Roland Seifert & Bastian Schirmer. (2020) A simple mechanistic terminology of psychoactive drugs: a proposal. Naunyn-Schmiedeberg's Archives of Pharmacology 393:8, pages 1331-1339.
Crossref
Crossref
Gerasimos N. Konstantinou, Simone N. Vigod, Shobha Mehta, Zafiris J. Daskalakis & Daniel M. Blumberger. (2020) “A systematic review of non-invasive neurostimulation for the treatment of depression during pregnancy”. Journal of Affective Disorders 272, pages 259-268.
Crossref
Crossref
Eva Češková & Martin Hýža. (2020) Treatment possibilities of pharmaco-resistant schizofrenie in common clinical practice. Psychiatrie pro praxi 21:2, pages 78-82.
Crossref
Crossref
Rashita Makkar, Tapan Behl, Simona Bungau, Gokhan Zengin, Vineet Mehta, Arun Kumar, Md. Sahab Uddin, Ghulam Md. Ashraf, Mohamed M. Abdel-Daim, Sandeep Arora & Roxana Oancea. (2020) Nutraceuticals in Neurological Disorders. International Journal of Molecular Sciences 21:12, pages 4424.
Crossref
Crossref
Ayman Guirguis, Joseph Chilcot, Michael Almond, Andrew Davenport, David Wellsted & Ken Farrington. (2020) Antidepressant Usage in Haemodialysis Patients: Evidence of Sub‐Optimal Practice Patterns. Journal of Renal Care 46:2, pages 124-132.
Crossref
Crossref
Rakesh Jain, Jonathan Meyer, Angela Wehr, Bhaskar Rege, Lisa von Moltke & Peter J. Weiden. (2019) Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia. CNS Spectrums 25:3, pages 323-330.
Crossref
Crossref
Andrea Carlo Rossetti, Maria Serena Paladini, Marco Andrea Riva & Raffaella Molteni. (2020) Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention. Pharmacology & Therapeutics 210, pages 107520.
Crossref
Crossref
Chen Zhu, Xinwei Li, Bangyi Zhao, Weiqing Peng, Wei Li & Wei Fu. (2020) Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy. European Journal of Medicinal Chemistry 193, pages 112214.
Crossref
Crossref
Philip D. Harvey, Hiroshi Nakamura & Sadanori Miura. (2019) Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study. Neuropsychopharmacology Reports 40:1, pages 63-72.
Crossref
Crossref
Anna K. Schmidtner, David A. Slattery, Joachim Gläsner, Andreas Hiergeist, Katharina Gryksa, Victoria A. Malik, Julian Hellmann-Regen, Isabella Heuser, Thomas C. Baghai, André Gessner, Rainer Rupprecht, Barbara Di Benedetto & Inga D. Neumann. (2019) Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner. Translational Psychiatry 9:1.
Crossref
Crossref
Miloslav Kopeček. (2019) Brexpiprazole. Praktické lékárenství 15:E-verze 1/19.
Crossref
Crossref
Samuel W. Centanni, Bridget D. Morris, Joseph R. Luchsinger, Gaurav Bedse, Tracy L. Fetterly, Sachin Patel & Danny G. Winder. (2018) Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. Neuropsychopharmacology 44:3, pages 526-537.
Crossref
Crossref
V. V. Gultyaeva, M. I. Zinchenko, D. Y. Uryumtsev, S. G. Krivoschekov & L. I. Aftanas. (2019) Exercise for depression treatment. Physiological mechanisms. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:7, pages 112.
Crossref
Crossref
Deborah Galvão Coelho da Silva, Luiz Kae Sales Kanazawa & Débora Dalla Vecchia. (2019) Schizophrenia: effects of aripiprazole in metabolic syndrome. Brazilian Journal of Pharmaceutical Sciences 55.
Crossref
Crossref
Christian C. Felder. 2019. Neuropsychotherapeutics. Neuropsychotherapeutics
1
20
.
Joseph P. Barsuglia, Martin Polanco, Robert Palmer, Benjamin J. Malcolm, Benjamin Kelmendi & Tanya Calvey. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience
121
158
.